32 /100
MEDIUM RISK
Score updated Apr 28, 2026

AVTX

Avalo Therapeutics, Inc. — Stock Dilution Tracker

Track AVTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track AVTX — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
50
🔄Convertible Debt
🌦️ Dilution Forecast
Watch
Minor dilution signals detected
12%
📜 Warrant Exercise 25%
• Significant warrants: 18% of shares outstanding
🔔 Track AVTX — Get forecast alerts →
💹 Market Data
Market Cap$294.43M
Shares Outstanding22.79M
Float20.14M
Cash$98.34M
Debt$427.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 36.2% shares (2025Q4 vs prior)
86 institutional holders · 21.29M shares
#1 BVF INC/IL 1.36M shares
#2 Nantahala Capital Management, LLC 1.24M shares
#3 BANK OF AMERICA CORP /DE/ 1.23M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest5.24M
Days to Cover6.1
% of Float26.0%
FINRA data as of Apr 15, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2024
4 INSIDER TRANSACTION Apr 08, 2026
4 INSIDER TRANSACTION Apr 03, 2026
4 INSIDER TRANSACTION Apr 03, 2026
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track AVTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AVTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for AVTX
📊 AVTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 AVTX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.